Clinical study of acupuncture on treating chemotherapy induced peripheral neuropathy

Beijing Hospital of Traditional Chinese Medicine, Capital Medical University0 个研究点开始时间: 待定最近更新: 2023年2月20日

研究概览

暂无简介。

•1.Patients with tumors diagnosed by pathological cytology or histology;
•2.There were numbness, hypoesthesia, pain and paresthesia in extremities after chemotherapy with platinum or taxanes. Some patients have muscle spasm, muscle weakness, myalgia, and even paralysis;
•3.Peripheral neuropathy of grade 1 or above according to NCI adverse reaction evaluation criteria within 7 days to 2 years after stopping chemotherapy;
•4.The main TCM syndrome is qi deficiency and blood stasis;
•5.The Eastern Oncology Cooperative Group (EOCG) score is 0-3;
•6.The expected survival time is more than 3 months.

•1.Patients receiving other medications that may cause neurotoxicity;
•2.Receive any drugs that are suspected to be effective, such as tricyclic antidepressants or anticonvulsants;
•3.Patients with severe heart, liver, kidney, immune and hematopoietic system diseases;
•4.Pregnant women and lactating women;
•5.Patients are fear of acupuncture, allergy to stainless steel needle and other reasons can not accept acupuncture treatment.

发起方

Beijing Hospital of Traditional Chinese Medicine, Capital Medical University